☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
AC Immune
AC Immune Reports Results of ACI-24.060 in P-Ib/II Trial for the Treatment of Alzheimer’s Disease and Down Syndrome
January 27, 2023
PharmaShots Weekly Snapshots (August 30 - September 03, 2021)
September 3, 2021
Genentech and AC Immune's Semorinemab Flounders in P-II TAURIEL Study for Early Alzheimer's Disease
September 24, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.